Infant Bacterial Therapeutics AB (IFTBF)
6.18
0.00 (0.00%)
USD |
OTCM |
Jun 09, 16:00
Infant Bacterial Therapeutics Total Assets (Quarterly) : 15.02M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 15.02M |
| December 31, 2025 | 17.55M |
| September 30, 2025 | 18.95M |
| June 30, 2025 | 20.28M |
| March 31, 2025 | 20.70M |
| December 31, 2024 | 21.68M |
| September 30, 2024 | 23.61M |
| June 30, 2024 | 27.99M |
| March 31, 2024 | 32.63M |
| December 31, 2023 | 34.86M |
| September 30, 2023 | 35.60M |
| June 30, 2023 | 29.38M |
| March 31, 2023 | 32.18M |
| December 31, 2022 | 33.55M |
| September 30, 2022 | 35.72M |
| June 30, 2022 | 39.04M |
| March 31, 2022 | 43.99M |
| December 31, 2021 | 45.12M |
| September 30, 2021 | 48.17M |
| Date | Value |
|---|---|
| June 30, 2021 | 50.21M |
| March 31, 2021 | 51.76M |
| December 31, 2020 | 54.83M |
| September 30, 2020 | 53.67M |
| June 30, 2020 | 52.88M |
| March 31, 2020 | 52.80M |
| December 31, 2019 | 55.36M |
| September 30, 2019 | 55.47M |
| June 30, 2019 | 59.82M |
| March 31, 2019 | 60.49M |
| December 31, 2018 | 63.54M |
| September 30, 2018 | 66.32M |
| June 30, 2018 | 67.12M |
| March 31, 2018 | 71.32M |
| December 31, 2017 | 21.38M |
| September 30, 2017 | 10.17M |
| June 30, 2017 | 10.93M |
| March 31, 2017 | 11.30M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Orexo AB | 64.08M |
| Swedencare AB | 1.023B |
| Camurus AB | 520.47M |
| Moberg Pharma AB | 71.75M |
| AstraZeneca PLC | 114.02B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 6.354M |
| Shareholders Equity (Quarterly) | 8.668M |
| Current Ratio | 2.233 |